Skip Nav Destination
Issues
1 September 2001
ISSN 1078-0432
EISSN 1557-3265
The Biology Behind
Editorials
Minireview
Review
Advances in Brief
Regular Articles
Clinical Trials
Virus-directed, Enzyme Prodrug Therapy with Nitroimidazole Reductase: A Phase I and Pharmacokinetic Study of its Prodrug, CB19541
Guy Chung-Faye; Daniel Palmer; David Anderson; Joanna Clark; Mandy Downes; Joanna Baddeley; Syed Hussain; Philip I. Murray; Peter Searle; Leonard Seymour; Peter A. Harris; David Ferry; David J. Kerr
Cancer Biology, Immunology, Cytokines
Research Articles
Molecular Oncology, Markers, Clinical Correlates
Circulating HER-2/erbB-2/c-neu (HER-2) Extracellular Domain as a Prognostic Factor in Patients with Metastatic Breast Cancer: Cancer and Leukemia Group B Study 86621
Daniel F. Hayes; Hideko Yamauchi; Gloria Broadwater; Constance T. Cirrincione; Stephen P. Rodrigue; Donald A. Berry; Jerry Younger; Lawrence L. Panasci; Frederick Millard; David B. Duggan; Larry Norton; I. Craig Henderson
Prognostic Impact of Proteolytic Factors (Urokinase-Type Plasminogen Activator, Plasminogen Activator Inhibitor 1, and Cathepsins B, D, and L) in Primary Breast Cancer Reflects Effects of Adjuvant Systemic Therapy1
Nadia Harbeck; Uta Alt; Ursula Berger; Achim Krüger; Christoph Thomssen; Fritz Jänicke; Heinz Höfler; Ronald E. Kates; Manfred Schmitt
Reduction of p12DOC-1 Expression Is a Negative Prognostic Indicator in Patients with Surgically Resected Oral Squamous Cell Carcinoma1
Satoru Shintani; Mariko Mihara; Nagaaki Terakado; Yuuji Nakahara; Tomohiro Matsumura; Yohko Kohno; Hiroe Ohyama; Jim McBride; Ralph Kent; Randy Todd; Takanori Tsuji; David T. W. Wong
The Early Growth Response Gene EGR-1 Behaves as a Suppressor Gene That Is Down-Regulated Independent of ARF/Mdm2 but not p53 Alterations in Fresh Human Gliomas1
Antonella Calogero; Antonietta Arcella; Giorgia De Gregorio; Antonio Porcellini; Dan Mercola; Chaoting Liu; Vincenza Lombari; Massimo Zani; Giuseppe Giannini; Franco Maria Gagliardi; Riccardo Caruso; Alberto Gulino; Luigi Frati; Giuseppe Ragona
Prevalence of a Common Point Mutation in the Dihydropyrimidine Dehydrogenase (DPD) Gene within the 5′-Splice Donor Site of Intron 14 in Patients with Severe 5-Fluorouracil (5-FU)- related Toxicity Compared with Controls1
Martin Raida; Wolfgang Schwabe; Peter Häusler; André B. P. Van Kuilenburg; Albert H. Van Gennip; Detlev Behnke; Klaus Höffken
Experimental Therapeutics, Preclinical Pharmacology
Treatment with Low-Dose Interferon-α Restores the Balance between Matrix Metalloproteinase-9 and E-Cadherin Expression in Human Transitional Cell Carcinoma of the Bladder1
Joel W. Slaton; Takashi Karashima; Paul Perrotte; Keiji Inoue; Sun J. Kim; Jonathan Izawa; Daniel Kedar; David J. McConkey; Randall Millikan; Paul Sweeney; Chiaki Yoshikawa; Taro Shuin; Colin P. N. Dinney
Bone Marrow-derived Cells Contribute to Tumor Neovasculature and, When Modified to Express an Angiogenesis Inhibitor, Can Restrict Tumor Growth in Mice1
Andrew M. Davidoff; Catherine Y. C. Ng; Peggy Brown; Margaret A. Leary; William W. Spurbeck; Junfang Zhou; Edwin Horwitz; Elio F. Vanin; Arthur W. Nienhuis
Role of the Raf Signal Transduction Cascade in the in Vitro Resistance to the Anticancer Drug Doxorubicin1
Caroline R. Weinstein-Oppenheimer; Carlos F. Henríquez-Roldán; Julianne M. Davis; Patrick M. Navolanic; Oussama A. Saleh; Linda S. Steelman; Richard A. Franklin; Penni J. Robinson; Martin McMahon; James A. McCubrey
Expression of β-Tubulin Isotypes in Human Ovarian Carcinoma Xenografts and in a Sub-Panel of Human Cancer Cell Lines from the NCI-Anticancer Drug Screen: Correlation with Sensitivity to Microtubule Active Agents1
Maria Ines Nicoletti; Giorgio Valoti; Paraskevi Giannakakou; Zhirong Zhan; Jon-Hyeok Kim; Valeria Lucchini; Fabio Landoni; Joseph G. Mayo; Raffaella Giavazzi; Tito Fojo
Advertisement
